Quarterly report · Q2
4539.TEDINET S100PJDF
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥32.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥167m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥206m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥752m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥258m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥258m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥700m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥228m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥228m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥50.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥49.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥48.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.7bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥31.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.2bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.2bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥351m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥148m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥35m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥576m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥793m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥340m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥248.43 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.51 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.33 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.24 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 37.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥16m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥183m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥167m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥480m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥460m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥30m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥30m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥15.1bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥15.1bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥10m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥194m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥206m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent liabilities | Prior1YearInstant | 14202000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 15822000000 | JPY |
| Liabilities | Prior1YearInstant | 30952000000 | JPY |
| Liabilities | CurrentQuarterInstant | 31683000000 | JPY |
| Capital stock | Prior1YearInstant | 4304000000 | JPY |
| Capital stock | CurrentQuarterInstant | 4304000000 | JPY |
| Capital surplus | Prior1YearInstant | 1263000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1263000000 | JPY |
| Retained earnings | Prior1YearInstant | 13482000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 14196000000 | JPY |
| Treasury stock | Prior1YearInstant | -3110000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -3110000000 | JPY |
| Shareholders equity | Prior1YearInstant | 15939000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 16653000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 547000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 244000000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 2070000000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | 2070000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -170000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -100000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 98000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 89000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2545000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2304000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 17000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 17000000 | JPY |
| Net assets | Prior1YearInstant | 18501000000 | JPY |
| Net assets | CurrentQuarterInstant | 18974000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 49453000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 50658000000 | JPY |
| Net sales | Prior1YTDDuration | 15575000000 | JPY |
| Net sales | CurrentYTDDuration | 16237000000 | JPY |
| Cost of sales | Prior1YTDDuration | 11265000000 | JPY |
| Cost of sales | CurrentYTDDuration | 11976000000 | JPY |
| Gross profit | Prior1YTDDuration | 4309000000 | JPY |
| Gross profit | CurrentYTDDuration | 4261000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 4103000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 4093000000 | JPY |
| Operating income | Prior1YTDDuration | 206000000 | JPY |
| Operating income | CurrentYTDDuration | 167000000 | JPY |
| Interest income noi | Prior1YTDDuration | 0 | JPY |
| Interest income noi | CurrentYTDDuration | 0 | JPY |
| Dividends income noi | Prior1YTDDuration | 15000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 17000000 | JPY |
| Rent income on noncurrent assets noi | Prior1YTDDuration | 3000000 | JPY |
| Rent income on noncurrent assets noi | CurrentYTDDuration | 3000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 14000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 16000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 74000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 612000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |